Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALNT Allient	$29.88 -1.8%	$23.91	$16.91 ▼ $32.95	$505.84M	1.39	116,951 shs	109,429 shs
EYPT EyePoint Pharmaceuticals	$5.68 +1.4%	$5.82	$3.91 ▼ $13.99	$390.85M	1.58	815,934 shs	368,862 shs
LAB Standard BioTools	$0.92 -3.4%	$1.12	$0.92 ▼ $2.65	$350.04M	1.8	2.14 million shs	2.59 million shs
RPID Rapid Micro Biosystems	$3.27 +3.8%	$2.53	$0.58 ▼ $4.04	$143.33M	1.13	189,908 shs	60,991 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALNT Allient	0.00%	-7.20%	+38.27%	+12.02%	+5.84%
EYPT EyePoint Pharmaceuticals	0.00%	-7.34%	-13.15%	-7.64%	-50.48%
LAB Standard BioTools	0.00%	-14.67%	-25.07%	-29.11%	-64.42%
RPID Rapid Micro Biosystems	0.00%	+1.87%	+40.95%	+1.87%	+289.75%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALNT Allient	2.6375 of 5 stars	1.3	3.0	1.7	3.5	2.5	2.5
EYPT EyePoint Pharmaceuticals	2.0996 of 5 stars	3.5	2.0	0.0	3.4	1.7	0.0
LAB Standard BioTools	2.0721 of 5 stars	3.3	0.0	0.0	2.3	4.2	0.6
RPID Rapid Micro Biosystems	1.244 of 5 stars	2.0	3.0	0.0	0.0	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALNT Allient	2.50	Moderate Buy	$31.00	3.75% Upside
EYPT EyePoint Pharmaceuticals	3.00	Buy	$25.38	346.74% Upside
LAB Standard BioTools	2.50	Moderate Buy	$2.50	171.27% Upside
RPID Rapid Micro Biosystems	4.00	Strong Buy	$8.00	144.65% Upside

Current Analyst Ratings Breakdown

Latest RPID, ALNT, EYPT, and LAB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/16/2025	EYPT EyePoint Pharmaceuticals	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$30.00 ➝ $26.00
5/8/2025	EYPT EyePoint Pharmaceuticals	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$33.00 ➝ $27.00
5/5/2025	ALNT Allient	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$35.00
5/5/2025	ALNT Allient	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/5/2025	ALNT Allient	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
3/6/2025	EYPT EyePoint Pharmaceuticals	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$33.00 ➝ $33.00
3/6/2025	EYPT EyePoint Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00 ➝ $22.00
2/27/2025	LAB Standard BioTools	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Sector Weight

(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALNT Allient	$516.06M	0.98	$4.36 per share	6.86	$15.52 per share	1.93
EYPT EyePoint Pharmaceuticals	$56.04M	6.97	N/A	N/A	$5.66 per share	1.00
LAB Standard BioTools	$169.69M	2.06	N/A	N/A	($1.85) per share	-0.50
RPID Rapid Micro Biosystems	$29.65M	4.83	N/A	N/A	$2.78 per share	1.18

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALNT Allient	$24.10M	$0.59	33.95	16.33	N/A	2.64%	10.80%	4.75%	8/6/2025 (Estimated)
EYPT EyePoint Pharmaceuticals	-$70.79M	-$2.41	N/A	N/A	N/A	-226.57%	-43.01%	-31.63%	8/6/2025 (Estimated)
LAB Standard BioTools	-$74.66M	-$0.35	N/A	N/A	N/A	-79.92%	-27.05%	-15.52%	7/30/2025 (Estimated)
RPID Rapid Micro Biosystems	-$52.47M	-$1.03	N/A	N/A	N/A	-184.93%	-48.05%	-39.18%	8/1/2025 (Estimated)

Latest RPID, ALNT, EYPT, and LAB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/9/2025	Q1 2025	RPID Rapid Micro Biosystems	-$0.27	-$0.26	+$0.01	-$0.26	$6.63 million	$7.21 million
5/7/2025	Q1 2025	ALNT Allient	$0.33	$0.46	+$0.13	$0.21	$125.00 million	$134.62 million
5/7/2025	Q1 2025	EYPT EyePoint Pharmaceuticals	-$0.65	-$0.65	N/A	-$0.65	$8.84 million	$24.50 million
3/5/2025	Q4 2024	ALNT Allient	$0.28	$0.31	+$0.03	$0.18	$119.72 million	$122.01 million
3/5/2025	Q4 2024	EYPT EyePoint Pharmaceuticals	-$0.54	-$0.64	-$0.10	-$0.64	$11.02 million	$11.60 million
2/28/2025	Q4 2024	RPID Rapid Micro Biosystems	-$0.22	-$0.22	N/A	-$0.22	$8.20 million	$8.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALNT Allient	$0.12	0.40%	+4.55%	20.34%	N/A
EYPT EyePoint Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
LAB Standard BioTools	N/A	N/A	N/A	N/A	N/A
RPID Rapid Micro Biosystems	N/A	N/A	N/A	N/A	N/A

Latest RPID, ALNT, EYPT, and LAB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/7/2025	ALNT Allient	quarterly	$0.03	0.4%	5/22/2025	5/22/2025	6/5/2025
3/5/2025	ALNT Allient	quarterly	$0.03	0.51%	3/20/2025	3/20/2025	4/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALNT Allient	0.85	4.10	2.18
EYPT EyePoint Pharmaceuticals	N/A	5.50	5.45
LAB Standard BioTools	N/A	3.76	3.41
RPID Rapid Micro Biosystems	N/A	5.52	4.19

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALNT Allient	61.57%
EYPT EyePoint Pharmaceuticals	99.41%
LAB Standard BioTools	53.74%
RPID Rapid Micro Biosystems	52.60%

Insider Ownership

Company	Insider Ownership
ALNT Allient	14.90%
EYPT EyePoint Pharmaceuticals	4.74%
LAB Standard BioTools	23.16%
RPID Rapid Micro Biosystems	29.96%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALNT Allient	1,950	16.93 million	14.22 million	Optionable
EYPT EyePoint Pharmaceuticals	120	68.81 million	65.02 million	Optionable
LAB Standard BioTools	620	379.82 million	174.59 million	Optionable
RPID Rapid Micro Biosystems	200	43.83 million	29.95 million	Not Optionable

RPID, ALNT, EYPT, and LAB Headlines

Recent News About These Companies

Rapid Micro Biosystems (NASDAQ:RPID) Posts Earnings Results, Beats Expectations By $0.01 EPS

May 13, 2025 | marketbeat.com

Earnings call transcript: Rapid Micro Biosystems Q1 2025 shows revenue growth

May 10, 2025 | investing.com

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2025 Earnings Call Transcript

May 10, 2025 | msn.com

Rapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2025 Financial Results

May 10, 2025 | finanznachrichten.de

Why Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Up 26.12%

May 9, 2025 | aaii.com

Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript

May 9, 2025 | seekingalpha.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates

May 9, 2025 | zacks.com

Rapid Micro Biosystems Reports First Quarter 2025 Financial Results

May 9, 2025 | globenewswire.com

Rapid Micro Biosystems (RPID) to Release Earnings on Friday

April 27, 2025 | marketbeat.com

Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025

April 24, 2025 | globenewswire.com

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) largest shareholders are retail investors with 36% ownership, private equity firms own 33%

April 21, 2025 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (RPID): A Bull Case Theory

April 4, 2025 | insidermonkey.com

Is Rapid Micro Biosystems Inc. (RPID) the Popular Penny Stock on Robinhood to Watch?

March 27, 2025 | msn.com

Is Rapid Micro Biosystems (RPID) One of the Penny Stocks With Huge Upside Potential According to Analysts?

March 23, 2025 | insidermonkey.com

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 12, 2025 | globenewswire.com

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2024 Earnings Call Transcript

March 3, 2025 | insidermonkey.com

Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript

March 2, 2025 | seekingalpha.com

Rapid Micro Biosystems Reports Strong 2024 Financial Growth

February 28, 2025 | tipranks.com

Rapid Micro Biosystems stock tumbles on earnings miss, weak outlook

February 28, 2025 | in.investing.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates

February 28, 2025 | zacks.com

Rapid Micro Biosystems Shares Rise in Premarket on New Distribution Agreement with Merck

February 28, 2025 | marketwatch.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID, ALNT, EYPT, and LAB Company Descriptions

Allient NASDAQ:ALNT

$29.88 -0.56 (-1.84%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$29.88 +0.01 (+0.02%)

As of 05/23/2025 04:04 PM Eastern

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

EyePoint Pharmaceuticals NASDAQ:EYPT

$5.68 +0.08 (+1.43%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$5.60 -0.08 (-1.41%)

As of 05/23/2025 06:23 PM Eastern

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Standard BioTools NASDAQ:LAB

$0.92 -0.03 (-3.45%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.96 +0.04 (+4.17%)

As of 05/23/2025 07:55 PM Eastern

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Rapid Micro Biosystems NASDAQ:RPID

$3.27 +0.12 (+3.81%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$3.12 -0.15 (-4.43%)

As of 05/23/2025 07:50 PM Eastern

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time